Page last updated: 2024-11-02

fenclonine and Maternal Phenylalanine Hydroxylase Deficiency Disease

fenclonine has been researched along with Maternal Phenylalanine Hydroxylase Deficiency Disease in 1 studies

Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.

Research Excerpts

ExcerptRelevanceReference
"This work attempts to study the cerebral alterations in rat offspring of hyperphenylalaninemic mothers, as well as the possibility of preventing them by means of administration of dietetic supplements of valine, leucine and isoleucine during the pregnancy."3.70[An experimental study on the effects of maternal hyperphenylalaninemia on the central nervous system and behavior of offspring rats]. ( Baldellou Vázquez, A; García Vera, C; Gracia Romero, J; Pérez-González, J; Ventura Faci, P, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García Vera, C1
Baldellou Vázquez, A1
Gracia Romero, J1
Ventura Faci, P1
Pérez-González, J1

Other Studies

1 other study available for fenclonine and Maternal Phenylalanine Hydroxylase Deficiency Disease

ArticleYear
[An experimental study on the effects of maternal hyperphenylalaninemia on the central nervous system and behavior of offspring rats].
    Anales espanoles de pediatria, 1998, Volume: 48, Issue:1

    Topics: Amino Acids, Branched-Chain; Animals; Animals, Newborn; Behavior, Animal; Brain; Enzyme Inhibitors;

1998